Investing.com - ADMA Biologics (NASDAQ:ADMA) Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
ADMA Biologics Inc announced earnings per share of $-0.0800 on revenue of $41.09M. Analysts polled by Investing.com anticipated EPS of $-0.0700 on revenue of $34.03M.
ADMA Biologics Inc shares are up 4.35% from the beginning of the year, still down 15.41% from its 52 week high of $2.92 set on September 8.
ADMA Biologics Inc follows other major Healthcare sector earnings this month
ADMA Biologics Inc's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar